Hemoptysis and Behçet's syndrome

Journal of Rheumatology

Volumn 36, Issue 4, 2009, Pages 848-849

  Peall, Adrian F ^a   Jones, Sharon M ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTERIAL CIRCULATION; ARTICLE; ARTIFICIAL EMBOLISM; BEHCET DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; HEMOPTYSIS; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PULMONARY ARTERY ANEURYSM; THORAX RADIOGRAPHY; VISUAL IMPAIRMENT; PATHOLOGY; TREATMENT OUTCOME;

ADULT; BEHCET SYNDROME; EMBOLIZATION, THERAPEUTIC; HEMOPTYSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TREATMENT OUTCOME;

EID: 66149088056     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080900     Document Type: Article

References (5)

1. Raz I, Okon E, Chajek-Shoul T. Pulmonary manifestations in Behcet's syndrome. Chest 1989;95:585-9.
2. Tunaci M, Ozkokmaz B, Tunaci A, et al. CT findings of pulmonary artery aneurysms during treatment for Behcet's disease. AJR Am J Roentgenol 1999;172:729-33.
3. Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in Behcet's disease: a cumulative analysis. Chest 2005;127:2243-53.
4. Sfikakis PP, Markomichelakis N, Alpsoy E, et al. Anti-TNF therapy in the management of Behcet's disease - review and basis for recommendations. Rheumatology Oxford 2007;46:736-41.
5. Baki K, Villiger PM, Jenni D, Meyer T, Beer JH. Behcet's disease with life threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab. Ann Rheum Dis 2006;65:1531-2.